Publications by authors named "E Baum-Jones"

Background: Gastroschisis is a birth defect with the greatest risk among women <20 years of age.

Methods: Pregnant women attending the University of Utah's Maternal-Fetal Medicine Diagnostic Center between 2011 and 2017 for either their routine diagnostic ultrasound or referral were recruited (cases: pregnant women with fetal gastroschisis, n = 53 participated/57, 93%; controls: pregnant women without fetal abnormalities, n = 102 participated/120, 85%). A clinic coordinator consented and interviewed women and obtained a blood sample and prenatal medical records.

View Article and Find Full Text PDF
Article Synopsis
  • This study focuses on understanding how mRNA-based vaccines, specifically mRNA-1273, generate immune responses by examining the antibody epitope profiles in response to the SARS-CoV-2 spike protein.
  • Researchers analyzed serum samples from clinical trial participants who received the mRNA-1273 vaccine, both after the primary series and following a booster dose, to identify specific antibody responses.
  • Findings revealed that while initial antibody signals decreased over time, they significantly increased again after a booster, and certain booster formulations, like variant-updated vaccines, resulted in stronger antibody responses compared to the original mRNA-1273 booster.
View Article and Find Full Text PDF

Sero-surveillance can monitor and project disease burden and risk. However, SARS-CoV-2 antibody test results can produce false positive results, limiting their efficacy as a sero-surveillance tool. False positive SARS-CoV-2 antibody results are associated with malaria exposure, and understanding this association is essential to interpret sero-surveillance results from malaria-endemic countries.

View Article and Find Full Text PDF

As Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to spread, characterization of its antibody epitopes, emerging strains, related coronaviruses, and even the human proteome in naturally infected patients can guide the development of effective vaccines and therapies. Since traditional epitope identification tools are dependent upon pre-defined peptide sequences, they are not readily adaptable to diverse viral proteomes. The Serum Epitope Repertoire Analysis (SERA) platform leverages a high diversity random bacterial display library to identify proteome-independent epitope binding specificities which are then analyzed in the context of organisms of interest.

View Article and Find Full Text PDF

Reverse vaccinology is an evolving approach for improving vaccine effectiveness and minimizing adverse responses by limiting immunizations to critical epitopes. Towards this goal, we sought to identify immunogenic amino acid motifs and linear epitopes of the SARS-CoV-2 spike protein that elicit IgG in COVID-19 mRNA vaccine recipients. Paired pre/post vaccination samples from N = 20 healthy adults, and post-vaccine samples from an additional N = 13 individuals were used to immunoprecipitate IgG targets expressed by a bacterial display random peptide library, and preferentially recognized peptides were mapped to the spike primary sequence.

View Article and Find Full Text PDF